Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

8
Number of overlapping holdings
28.6%
% of PBE's 28 holdings also in GNOM
20.5%
% of GNOM's 39 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PBE |
Weight in GNOM |
Overlap | |
---|---|---|---|---|
NATERA INC | 5.4% | 7.1% | 5.4% | |
GILEAD SCIENCES INC | 5.3% | 3.4% | 3.4% | |
VERACYTE INC | 2.9% | 5.5% | 2.9% | |
ILLUMINA INC | 4.2% | 2.8% | 2.8% | |
BIOMARIN PHARMACEUTICAL INC | 2.6% | 4.8% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to GNOM
AMGEN INC | 5.0% | |
NEUROCRINE BIOSCIENCES INC | 4.9% | |
BIOGEN IDEC INC | 4.7% | |
UNITED THERAPEUTICS CORP | 4.5% | |
REGENERON PHARMACEUTICALS | 4.4% | |
PROTAGONIST THERAPEUTICS, INC. | 4.1% | |
TG THERAPEUTICS INC | 4.0% | |
CATALYST PHARMACEUTICAL PART | 3.3% | |
HALOZYME THERAPEUTICS INC | 3.1% | |
EXELIXIS INC | 3.0% |
PBE Underweight Relative to GNOM
BIONTECH SE SPONSORED ADR | -5.1% | |
CRISPR THERAPEUTICS AG | -4.7% | |
ALNYLAM PHARMACEUTICALS INC | -4.5% | |
AGILENT TECHNOLOGIES INC | -4.4% | |
LEGEND BIOTECH CORPORATION SPONSORED | -4.2% | |
GENSCRIPT BIOTECH CORPORATION | -3.8% | |
ULTRAGENYX PHARMACEUTICAL IN | -3.7% | |
AVIDITY BIOSCIENCES INC | -3.3% | |
BEAM THERAPEUTICS, INC. | -3.3% | |
ARROWHEAD PHARMACEUTICALS, INC. | -3.2% |